ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹438 Cr | ₹589 Cr | ₹531 Cr | ₹129 Cr | ₹144 Cr |
What is the latest Net Current Assets ratio of ORCHID PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹438 Cr |
| Mar2025 | ₹589 Cr |
| Mar2024 | ₹531 Cr |
| Mar2023 | ₹129 Cr |
| Mar2022 | ₹144 Cr |
How is Net Current Assets of ORCHID PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹438 Cr | -25.65 | |
| Mar2025 | ₹589 Cr | 10.93 | |
| Mar2024 | ₹531 Cr | 311.08 | |
| Mar2023 | ₹129 Cr | -10.07 | |
| Mar2022 | ₹144 Cr | - | |
Compare Net Current Assets of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹5,292.8 Cr | 0.7% | -10.1% | 12% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 0.7% |
-10.1% |
12% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses